9.30
Evolent Health Inc stock is traded at $9.30, with a volume of 2.01M.
It is up +5.44% in the last 24 hours and down -18.21% over the past month.
Evolent Health Inc is engaged in healthcare delivery and payment. The company supports health systems and physician organizations in their migration toward value-based care and population health management. It provides specialty care management services in oncology, cardiology, musculoskeletal markets and holistic total cost of care management along with an integrated platform for health plan administration and value-based business infrastructure under one go to market package. The primary solutions provided by the company include specialty care management services, total cost of care management, and administrative services.
See More
Previous Close:
$8.82
Open:
$8.98
24h Volume:
2.01M
Relative Volume:
0.77
Market Cap:
$1.09B
Revenue:
$2.35B
Net Income/Loss:
$-74.42M
P/E Ratio:
-9.8936
EPS:
-0.94
Net Cash Flow:
$150.93M
1W Performance:
+3.33%
1M Performance:
-18.21%
6M Performance:
-7.19%
1Y Performance:
-65.80%
Evolent Health Inc Stock (EVH) Company Profile
Name
Evolent Health Inc
Sector
Industry
Phone
571-389-6000
Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON
Compare EVH with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
EVH
Evolent Health Inc
|
9.30 | 1.04B | 2.35B | -74.42M | 150.93M | -0.94 |
![]()
VEEV
Veeva Systems Inc
|
280.61 | 45.62B | 2.86B | 780.66M | 1.19B | 4.72 |
![]()
TEM
Tempus Ai Inc
|
73.78 | 12.10B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
65.13 | 11.99B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
89.89 | 7.72B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
36.08 | 6.16B | 906.14M | -52.62M | 89.62M | -0.3621 |
Evolent Health Inc Stock (EVH) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-10-25 | Initiated | Needham | Buy |
Dec-03-24 | Reiterated | BTIG Research | Buy |
Nov-08-24 | Downgrade | Stephens | Overweight → Equal-Weight |
Oct-11-24 | Initiated | KeyBanc Capital Markets | Overweight |
Aug-09-24 | Upgrade | Truist | Hold → Buy |
Apr-22-24 | Initiated | Citigroup | Buy |
Mar-01-24 | Initiated | Oppenheimer | Outperform |
Jan-03-24 | Initiated | Barclays | Overweight |
Dec-06-23 | Initiated | JMP Securities | Mkt Outperform |
Oct-16-23 | Initiated | UBS | Buy |
Apr-12-23 | Initiated | Stephens | Overweight |
Nov-01-22 | Initiated | Truist | Hold |
Jul-29-22 | Initiated | RBC Capital Mkts | Outperform |
Mar-30-22 | Initiated | Guggenheim | Buy |
Nov-18-21 | Upgrade | JP Morgan | Neutral → Overweight |
Apr-29-21 | Resumed | JP Morgan | Neutral |
Jan-07-21 | Initiated | BTIG Research | Buy |
Jul-06-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
Jun-05-20 | Downgrade | Goldman | Buy → Neutral |
Jun-02-20 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
Oct-05-18 | Resumed | Leerink Partners | Outperform |
Jun-04-18 | Initiated | Piper Jaffray | Overweight |
Apr-24-18 | Resumed | JP Morgan | Neutral |
Sep-20-17 | Initiated | KeyBanc Capital Mkts | Overweight |
Jun-02-17 | Initiated | Robert W. Baird | Outperform |
Mar-14-17 | Initiated | Oppenheimer | Outperform |
Jan-13-17 | Upgrade | Wells Fargo | Market Perform → Outperform |
Oct-28-16 | Resumed | JP Morgan | Overweight |
Aug-05-16 | Reiterated | FBR Capital | Outperform |
Jul-26-16 | Initiated | Jefferies | Buy |
Jul-13-16 | Reiterated | FBR Capital | Outperform |
Mar-29-16 | Initiated | FBR Capital | Outperform |
Jan-06-16 | Initiated | Canaccord Genuity | Buy |
Jun-30-15 | Initiated | Goldman | Buy |
Jun-30-15 | Initiated | JP Morgan | Overweight |
Jun-30-15 | Initiated | Leerink Partners | Outperform |
Jun-30-15 | Initiated | Sun Trust Rbsn Humphrey | Buy |
View All
Evolent Health Inc Stock (EVH) Latest News
Evolent Health, Inc. (EVH) Shareholders May Have Been Affected by FraudLevi & Korsinsky Investigates - ACCESS Newswire
An Investigation Has Commenced on Behalf of Evolent Health, Inc. Shareholders. Contact Levi & Korsinsky to Discuss your EVH Losses - ACCESS Newswire
How Evolent Health’s Steep Revenue Drop and Forecast Will Impact EVH Investors - simplywall.st
5 Insightful Analyst Questions From Evolent Health’s Q2 Earnings Call - ca.finance.yahoo.com
Evolent Health’s SWOT analysis: stock faces challenges, shows resilience - Investing.com India
Brookdale, Evolent Health, Fortrea, 10x Genomics, and Organon Stocks Trade Up, What You Need To Know - Yahoo Finance
Evolent Health’s SWOT analysis: stock faces challenges, shows resilience By Investing.com - Investing.com Australia
Shareholder Rights Advocates at Levi & Korsinsky Investigate Evolent Health, Inc. (EVH) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Evolent Health at Canaccord Conference: Strategic Growth and Challenges By Investing.com - Investing.com Canada
Evolent Health’s Earnings Call: Balancing Growth and Challenges - MSN
Is This the Dip to Buy in Evolent Health Inc.Weekly Stock Recap & Low Volatility Stock Recommendations - 선데이타임즈
Evolent Health, Inc. (NYSE:EVH) Q2 2025 Earnings Call Transcript - Insider Monkey
Centene, RadNet, Evolent Health, Illumina, and Charles River Laboratories Shares Are Soaring, What You Need To Know - Yahoo Finance
EVH ACTIVE INVESTIGATION: Contact Levi & Korsinsky If You Lost Money On Your Evolent Health, Inc. investment - ACCESS Newswire
Candlestick Reversal Detected on Evolent Health Inc.’s ChartFast Gaining Stock Screener Reports Released - beatles.ru
EVH Q2 Deep Dive: Revenue Falls Short, Guidance Cut as Margin Initiatives Continue - Yahoo Finance
Evolent Health, Inc. SEC 10-Q Report - TradingView
TD Cowen Maintains Evolent Health(EVH.US) With Buy Rating, Maintains Target Price $14 - 富途牛牛
Further Weakness as Evolent Health (NYSE:EVH) Drops 9.8% This Week, Taking Three-year Losses to 74% - 富途牛牛
Evolent Health (EVH) Bolsters Management Team - MSN
How volatile is Evolent Health Inc. stockCapital Doubling Stock Strategy - mustnews.co.kr
Evolent Health's Strategic Position in the Evolving Managed Care Landscape - AInvest
Evolent Health, Inc. 2025 Q2ResultsEarnings Call Presentation (NYSE:EVH) - Seeking Alpha
Should Evolent Health's (EVH) Declining Sales and Rising Losses Prompt Investor Reassessment of 2025 Outlook? - simplywall.st
Protect Your Investment: Contact Levi & Korsinsky About the Evolent Health, Inc. (EVH) Investigation - TradingView
Evolent Health (EVH) Stock Falls 13.9% on Disappointing Q2 ResultsNews and Statistics - IndexBox
Why Evolent Health (EVH) Stock Is Nosediving - Yahoo Finance
Earnings call transcript: Evolent Health’s Q2 2025 results miss forecasts - Investing.com
Evolent Health Q2 2025 slides reveal revenue drop amid rising debt leverage - Investing.com Canada
PTC Therapeutics and Evolent Health Receive Bullish Sentiments from Analysts - AInvest
Evolent Health (NYSE:EVH) Reports Sales Below Analyst Estimates In Q2 Earnings, Stock Drops - Yahoo Finance
Evolent Health Inc (EVH) Q2 2025 Earnings Call Highlights: Strong Partnerships and Revenue ... - Yahoo Finance
Evolent Health Inc (EVH) Q2 2025 Earnings Call Highlights: Strong Partnerships and Revenue ... By GuruFocus - Investing.com Canada
Truist Financial Maintains Evolent Health(EVH.US) With Buy Rating - 富途牛牛
Evolent Health Reports Q2 2025 Earnings and Growth Outlook - TipRanks
Evolent Health's Q2 2025 Earnings and Strategic Turnaround: A Sustainable Recovery or a Temporary Bounce? - AInvest
Evolent Health (EVH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Evolent Announces Second Quarter 2025 Results - The Malaysian Reserve
Evolent Health (EVH) Reports Q2 Loss, Misses Revenue Estimates - Yahoo Finance
Evolent Health: Q2 Earnings Snapshot - San Antonio Express-News
Evolent Health shares tumble 11% as Q2 results miss expectations By Investing.com - Investing.com Canada
Evolent Health Inc Reports Q2 2025 Earnings: EPS Loss of $0.44 M - GuruFocus
Evolent Health shares tumble 11% as Q2 results miss expectations - Investing.com
Evolent Health Inc earnings missed by $0.18, revenue fell short of estimates - Investing.com Australia
Earnings Flash (EVH) Evolent Health, Inc. Reports Q2 Revenue $444.3M, vs. FactSet Est of $459.6M - MarketScreener
(EVH) Evolent Health, Inc. Expects Q3 Revenue Range $460.0M$480.0M - MarketScreener
Earnings Flash (EVH) Evolent Health, Inc. Posts Q2 Adjusted Loss $0.10 per Share, vs. FactSet Est of $0.07 - MarketScreener
Evolent Health Quarterly Results: Financial Insights and Market TrendsNews and Statistics - IndexBox
Evolent Health (EVH) Q2 Earnings Report Preview: What To Look For - Yahoo Finance
What are Evolent Health Inc. company’s key revenue driversCapitalize on emerging industry trends - Jammu Links News
What is the dividend policy of Evolent Health Inc. stockMassive stock growth - Jammu Links News
Evolent Health Inc Stock (EVH) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):